Search | Page 10 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

    ... of a specific kind of transplant. In this transplant, blood from two donors will be used. Each donor will share one half of your HLA ... by institutional policies Donor must have adequate peripheral venous catheter access for leukapheresis or must agree to placement ...

    Clinical Trial last updated 04/29/2016 - 1:59pm.

  2. Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 (DFCI 10-106)

    ... syndrome (another type of cancer affecting the blood). Dexamethasone is commonly used, either alone, or in combination with ... to comply with an anti-thrombotic treatment regimen Peripheral neuropathy >/= Grade 2 ...

    Clinical Trial last updated 05/23/2016 - 3:45pm.

  3. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    ... filgrastim neupogen Biological: Peripheral blood stem cell The source of stem cells for all patients will be ...

    Clinical Trial last updated 05/09/2016 - 3:19pm.

  4. Clinical Trials Report for April 2014

    ... aplastic anemia who need treatment for significantly low blood cell counts. National Institutes of Health Clinical Center ... standard non-transplant therapy, who will receive a peripheral blood stem cell transplant. A malignant disease includes the ...

    Page last updated 04/18/2014 - 3:36pm.

  5. Allo vs Hypomethylating/Best Supportive Care in MDS (BMT CTN 1102)

    ... Allogeneic Hematopoietic Cell Transplant Bone marrow or peripheral blood stem cell transplant. The specific transplant treatment regimen will be ...

    Clinical Trial last updated 04/28/2016 - 10:50am.

  6. Allo HSCT Using RIC for Hematological Diseases

    ... to a fetus. Females of childbearing potential must have a blood test or urine study within 14 days prior to registration to rule out ... Other Name: Mycophenolate Mofetil Biological: Peripheral Blood Stem Cells On day 0, patients will receive an allogeneic ...

    Clinical Trial last updated 05/02/2016 - 9:29am.

  7. Clinical Trials Report for June 2015

    ... successful engraftment with CD3+ /CD19+ depleted peripheral stem cell grafts from mismatched donors. There are two ... drug named posaconazole in children with certain cancers, blood disorders, or transplantation of bone marrow or similar blood ...

    Page last updated 06/18/2015 - 11:47am.

  8. Clinical Trials Report for May 2015

    ... successful engraftment with CD3+ /CD19+ depleted peripheral stem cell grafts from mismatched donors. There are two ... drug named posaconazole in children with certain cancers, blood disorders, or transplantation of bone marrow or similar blood ...

    Page last updated 04/28/2015 - 11:38am.

  9. Clinical Trials Report for July 2015

    ... successful engraftment with CD3+ /CD19+ depleted peripheral stem cell grafts from mismatched donors. There are two ... drug named posaconazole in children with certain cancers, blood disorders, or transplantation of bone marrow or similar blood ...

    Page last updated 06/24/2015 - 1:43pm.

  10. Issues for Parents of Pediatric Bone Marrow Failure Patients

    ... at the Medical College of Wisconsin and director of the Blood and Bone Marrow Transplant Program at Children's Hospital of ... stem cells from either bone marrow, cord blood, or peripheral blood, and there are risks and benefits to each of those approaches. ...

    Page last updated 06/20/2011 - 12:10pm.